Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petco Health & Wellness Company (WOOF) Gains from Sales and Divestitures (2021 - 2026)

Petco Health & Wellness Company's Gains from Sales and Divestitures history spans 6 years, with the latest figure at $4.6 million for Q1 2026.

  • For Q1 2026, Gains from Sales and Divestitures fell 22.75% year-over-year to $4.6 million; the TTM value through Jan 2026 reached $4.6 million, down 22.75%, while the annual FY2026 figure was $4.6 million, 22.75% down from the prior year.
  • Gains from Sales and Divestitures reached $4.6 million in Q1 2026 per WOOF's latest filing, up from $4.2 million in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $6.0 million in Q1 2025 to a low of $926.0 in Q1 2022.
  • Average Gains from Sales and Divestitures over 5 years is $2.6 million, with a median of $2.3 million recorded in 2025.
  • Peak YoY movement for Gains from Sales and Divestitures: soared 151303.89% in 2023, then fell 22.75% in 2026.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $1.0 million in 2022, then surged by 148.27% to $2.6 million in 2023, then skyrocketed by 73.63% to $4.5 million in 2024, then fell by 5.78% to $4.2 million in 2025, then rose by 9.97% to $4.6 million in 2026.
  • Per Business Quant, the three most recent readings for WOOF's Gains from Sales and Divestitures are $4.6 million (Q1 2026), $4.2 million (Q4 2025), and $3.2 million (Q3 2025).